BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2459497)

  • 1. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase.
    Chen NT; Corey EJ; Folkman J
    Lab Invest; 1988 Oct; 59(4):453-9. PubMed ID: 2459497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiogenesis through modulation of collagen metabolism.
    Ingber D; Folkman J
    Lab Invest; 1988 Jul; 59(1):44-51. PubMed ID: 2455830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of angiogenesis by aurintricarboxylic acid.
    Gagliardi AR; Collins DC
    Anticancer Res; 1994; 14(2A):475-9. PubMed ID: 7517120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiogenesis by suramin.
    Gagliardi A; Hadd H; Collins DC
    Cancer Res; 1992 Sep; 52(18):5073-5. PubMed ID: 1381276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.
    Ingber DE; Madri JA; Folkman J
    Endocrinology; 1986 Oct; 119(4):1768-75. PubMed ID: 2428602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system.
    Maragoudakis ME; Sarmonika M; Panoutsacopoulou M
    J Pharmacol Exp Ther; 1989 Nov; 251(2):679-82. PubMed ID: 2478695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A substrate analog inhibitor for arylsulfatase reduces NK cell cytotoxicity.
    Zucker-Franklin D; Nabi ZF
    Biochem Biophys Res Commun; 1985 Jan; 126(1):540-3. PubMed ID: 3970705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid.
    Tanaka NG; Sakamoto N; Inoue K; Korenaga H; Kadoya S; Ogawa H; Osada Y
    Cancer Res; 1989 Dec; 49(23):6727-30. PubMed ID: 2479471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiostatic steroid with or without glucocorticoid activity on metastasis.
    Sakamoto N; Tanaka NG
    Invasion Metastasis; 1987; 7(4):208-16. PubMed ID: 2444551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization.
    McNatt LG; Weimer L; Yanni J; Clark AF
    J Ocul Pharmacol Ther; 1999 Oct; 15(5):413-23. PubMed ID: 10530702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
    Blei F; Wilson EL; Mignatti P; Rifkin DB
    J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist.
    Pisano C; Aulicino C; Vesci L; Casu B; Naggi A; Torri G; Ribatti D; Belleri M; Rusnati M; Presta M
    Glycobiology; 2005 Feb; 15(2):1C-6C. PubMed ID: 15496501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization.
    Li WW; Casey R; Gonzalez EM; Folkman J
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2898-905. PubMed ID: 1917393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin potentiation of 3T3-adipocyte stimulated angiogenesis: mechanisms of action on endothelial cells.
    Castellot JJ; Kambe AM; Dobson DE; Spiegelman BM
    J Cell Physiol; 1986 May; 127(2):323-9. PubMed ID: 2422184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel function of ascorbic acid as an angiostatic factor.
    Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
    Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of angiogenesis with synthetic heparin substitutes.
    Folkman J; Weisz PB; JoulliƩ MM; Li WW; Ewing WR
    Science; 1989 Mar; 243(4897):1490-3. PubMed ID: 2467380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
    Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
    J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiostatic activity and metabolism of cortisol in the chorioallantoic membrane (CAM) of the chick embryo.
    McNatt LG; Lane D; Clark AF
    J Steroid Biochem Mol Biol; 1992 Aug; 42(7):687-93. PubMed ID: 1380295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.
    Crum R; Szabo S; Folkman J
    Science; 1985 Dec; 230(4732):1375-8. PubMed ID: 2416056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
    Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.